Toxigenic Clostridium perfringens isolated from at-risk pediatric inflammatory bowel disease patients.

James KuoJasmina UzunovicAmanda JacobsonMichelle DouradoSarah GierkeManohary RajendramDaniela KeilbergJordan MarEmily StekolJoanna CurrySofia VerstraeteJessica LundYuxin LiangFiona B TamburiniNatalie S OmattageMatthieu MasureelSteven T RutherfordDavid H HackosMan-Wah TanAllyson L ByrdMary E KeirElizabeth SkippingtonKelly M Storek

Published in: Journal of Crohn's & colitis (2024)

Gastrointestinal carriage of certain toxigenic C. perfringens may have an important pathogenic impact on IBD patients. These findings support routine monitoring of C. perfringens and PFO toxins and potential treatment in patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
risk assessment
young adults
clostridium difficile
patient reported
human health